Reporting owner · CIK 0001313516
Jorden David Emerson
Visual SEC Form 4 history across 1 companies, 7 transactions and 3 filings.
CEO, CFOCEO/CFONuo Therapeutics, Inc.
Open-market mix
100%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Dec 18
$0
Jan 26
$0
Aug 26
$9.5K
Transaction texture
Ownership and ticket size
Average P/S size$4.8K
Median P/S size$4.8K
Direct7
Indirect0
Aug 28, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest sale
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| AURX | JORDEN DAVID EMERSON | CEOCFO | buy | 7.98k | $869k | P | — | 08/31 | 08/28 | |
| AURX | JORDEN DAVID EMERSON | CEOCFO | buy | 789 | $84.4k | P | — | 08/31 | 08/27 | |
| AURX | JORDEN DAVID EMERSON | CEOCFO | grant | 7.98k | $869k | A | — | 08/29 | 08/28 | |
| AURX | JORDEN DAVID EMERSON | CEOCFO | grant | 789 | $84.4k | A | — | 08/29 | 08/27 | |
| AURX | JORDEN DAVID EMERSON | CEOCFO | exercise | 125k | $0 | M | — | 01/06 | 12/31/2018 | |
| AURX | JORDEN DAVID EMERSON | CEOCFO | withholding | 25.3k | -$5.00M | F | — | 01/06 | 01/01 | |
| AURX | JORDEN DAVID EMERSON | CEOCFO | exercise | 125k | $5.00M | M | — | 01/06 | 01/01 |
Jorden David Emerson Insider Activity FAQ
SEC Form 4 context
Who is Jorden David Emerson?
Jorden David Emerson is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001313516.
Which companies has Jorden David Emerson reported transactions for?
Nuo Therapeutics, Inc.
When was Jorden David Emerson's latest insider buy?
buy at Nuo Therapeutics, Inc. on Aug 28, 2026 valued at $8,695.
When was Jorden David Emerson's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.